CG Oncology, Inc. (CGON)
54.92
-1.75
(-3.09%)
USD |
NASDAQ |
Jun 10, 16:00
54.98
+0.06
(+0.11%)
After-Hours: 20:00
CG Oncology 1 Year Total Returns (Daily) : 99.85% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 99.85% |
| June 09, 2026 | 109.9% |
| June 08, 2026 | 102.2% |
| June 05, 2026 | 101.7% |
| June 04, 2026 | 111.0% |
| June 03, 2026 | 103.1% |
| June 02, 2026 | 108.8% |
| June 01, 2026 | 131.2% |
| May 29, 2026 | 137.5% |
| May 28, 2026 | 140.2% |
| May 27, 2026 | 138.2% |
| May 26, 2026 | 143.3% |
| May 22, 2026 | 149.4% |
| May 21, 2026 | 146.3% |
| May 20, 2026 | 143.8% |
| May 19, 2026 | 154.6% |
| May 18, 2026 | 147.5% |
| May 15, 2026 | 164.0% |
| May 14, 2026 | 187.7% |
| May 13, 2026 | 206.0% |
| May 12, 2026 | 186.4% |
| May 11, 2026 | 192.0% |
| May 08, 2026 | 188.5% |
| May 07, 2026 | 209.7% |
| May 06, 2026 | 213.4% |
| Date | Value |
|---|---|
| May 05, 2026 | 138.4% |
| May 04, 2026 | 133.0% |
| May 01, 2026 | 138.9% |
| April 30, 2026 | 147.7% |
| April 29, 2026 | 140.3% |
| April 28, 2026 | 134.4% |
| April 27, 2026 | 198.7% |
| April 24, 2026 | 219.1% |
| April 23, 2026 | 237.1% |
| April 22, 2026 | 241.2% |
| April 21, 2026 | 252.0% |
| April 20, 2026 | 241.1% |
| April 17, 2026 | 255.8% |
| April 16, 2026 | 228.1% |
| April 15, 2026 | 236.5% |
| April 14, 2026 | 235.4% |
| April 13, 2026 | 251.1% |
| April 10, 2026 | 284.0% |
| April 09, 2026 | 285.6% |
| April 08, 2026 | 341.8% |
| April 07, 2026 | 312.6% |
| April 06, 2026 | 292.7% |
| April 02, 2026 | 203.4% |
| April 01, 2026 | 202.9% |
| March 31, 2026 | 176.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cogent Biosciences, Inc. | 322.9% |
| Vera Therapeutics, Inc. | 39.79% |
| Arrowhead Pharmaceuticals, Inc. | 316.8% |
| Oncolytics Biotech, Inc. | 87.38% |
| Sangamo Therapeutics, Inc. | -71.08% |